🔎 Trials Near Me

Beranda › Obesitas › Virginia › Arlington

Uji klinis Obesitas di Arlington, VA

18 studi untuk Obesitas mencari peserta di lokasi sekitar Arlington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 2
  • Washington Center For Weight Management And Research /ID# 282047, Arlington
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Menerima pesertaFase 2
  • Carient Heart and Vascular LLC-Reston, Reston · 14 mi jauhnya
  • Carient Heart & Vascular - Manassas, Manassas · 22 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07783802

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Menerima pesertaFase 3
  • Washington Cntr Weight Mgmt, Arlington
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07720271

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Menerima pesertaFase 3
  • Research Site, Manassas · 22 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07776509

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Menerima pesertaFase 3
  • Washington Cntr Weight Mgmt, Arlington
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07339423

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Menerima pesertaFase 3
  • Research Site, Manassas · 22 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Menerima pesertaFase 3
  • Virginia Heart, Falls Church · 4 mi jauhnya
  • Inova Cardiology - Fairfax, Fairfax · 11 mi jauhnya
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07037433

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Menerima pesertaFase 3
  • Conquest Research, LLC, Arlington
  • Virginia Heart, Falls Church · 4 mi jauhnya
  • Carient Heart and Vascular, Manassas · 22 mi jauhnya
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Menerima pesertaFase 3
  • Manassas Clinical Research Center, Manassas · 22 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Menerima pesertaFase 3Sukarelawan sehat diterima
  • ACCOMPLISH-2 Research Site, Burke · 11 mi jauhnya
  • ACCOMPLISH-2 Research Site, Manassas · 22 mi jauhnya
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07654374

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Menerima pesertaFase 3
  • Kailera Clinical Site, Manassas · 22 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Menerima pesertaFase 3
  • Washington Center for Weight Management and Research, Inc, Arlington
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Menerima pesertaFase 3
  • Manassas Clinical Research Center Inc, Manassas · 22 mi jauhnya
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Menerima pesertaFase 3
  • Kailera Clinical Site, Manassas · 22 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07284979

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Menerima pesertaFase 3
  • Research Site, Arlington
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07784725

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Menerima pesertaFase 3
  • Conquest Research, Vienna · 9 mi jauhnya
  • Carient Heart and Vascular, Manassas · 22 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07567001

Brief Inhibitory Training for Eating - Intervention

Menerima peserta
  • George Mason University, Fairfax · 11 mi jauhnya
Usia 14 hingga 17 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT07592728

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

Menerima pesertaFase 3Sukarelawan sehat diterima
  • Vanda Investigational Site, Burke · 11 mi jauhnya
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 20 Apr 2026 · NCT07446439

Uji klinis Obesitas di kota lain

Studi lain di Arlington

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.